Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter

2010 ◽  
Vol 470 (1) ◽  
pp. 65-70 ◽  
Author(s):  
Janet E. Holley ◽  
Jia Newcombe ◽  
Jacqueline L. Whatmore ◽  
Nicholas J. Gutowski
2020 ◽  
Vol 40 (1) ◽  
Author(s):  
Junyu Chen ◽  
Luciana Lippo ◽  
Rossella Labella ◽  
Sin Lih Tan ◽  
Brian D Marsden ◽  
...  

2017 ◽  
Vol 5 (24) ◽  
pp. 4660-4672 ◽  
Author(s):  
Robin Augustine ◽  
Susheel Kumar Nethi ◽  
Nandakumar Kalarikkal ◽  
Sabu Thomas ◽  
Chitta Ranjan Patra

PCL-EHNs scaffolds enhance endothelial cell proliferation, adhesion and blood vessel formation in a VEGFR2/Akt dependent signaling cascade.


1982 ◽  
Vol 79 (5) ◽  
pp. 269-276 ◽  
Author(s):  
Richard A.F. Clark ◽  
Patricia DellaPelle ◽  
Eleanor Manseau ◽  
Joan M. Lanigan ◽  
Harold F. Dvorak ◽  
...  

2009 ◽  
Vol 185 (4) ◽  
pp. 657-671 ◽  
Author(s):  
Mark Winderlich ◽  
Linda Keller ◽  
Giuseppe Cagna ◽  
Andre Broermann ◽  
Olena Kamenyeva ◽  
...  

Vascular endothelial protein tyrosine phosphatase (VE-PTP) is an endothelial-specific receptor-type tyrosine phosphatase that associates with Tie-2 and VE-cadherin. VE-PTP gene disruption leads to embryonic lethality, vascular remodeling defects, and enlargement of vascular structures in extraembryonic tissues. We show here that antibodies against the extracellular part of VE-PTP mimic the effects of VE-PTP gene disruption exemplified by vessel enlargement in allantois explants. These effects require the presence of the angiopoietin receptor Tie-2. Analyzing the mechanism we found that anti–VE-PTP antibodies trigger endocytosis and selectively affect Tie-2–associated, but not VE-cadherin–associated VE-PTP. Dissociation of VE-PTP triggers the activation of Tie-2, leading to enhanced endothelial cell proliferation and enlargement of vascular structures through activation of Erk1/2. Importantly, the antibody effect on vessel enlargement is also observed in newborn mice. We conclude that VE-PTP is required to balance Tie-2 activity and endothelial cell proliferation, thereby controlling blood vessel development and vessel size.


Angiogenesis ◽  
2021 ◽  
Author(s):  
Delphine M. Lees ◽  
Louise E. Reynolds ◽  
Ana Rita Pedrosa ◽  
Marina Roy-Luzarraga ◽  
Kairbaan M. Hodivala-Dilke

AbstractFocal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is overexpressed in many cancer types and in vivo studies have shown that vascular endothelial cell FAK expression and FAK-phosphorylation at tyrosine (Y) 397, and subsequently FAK-Y861, are important in tumour angiogenesis. Pericytes also play a vital role in regulating tumour blood vessel stabilisation, but the specific involvement of pericyte FAK-Y397 and FAK-Y861 phosphorylation in tumour blood vessels is unknown. Using PdgfrβCre + ;FAKWT/WT, PdgfrβCre + ;FAKY397F/Y397F and PdgfrβCre + ;FAKY861F/Y861F mice, our data demonstrate that tumour growth, tumour blood vessel density, blood vessel perfusion and pericyte coverage were affected only in late stage tumours in PdgfrβCre + ;FAKY861F/Y861F but not PdgfrβCre + ;FAKY397F/Y397F mice. Further examination indicates a dual role for pericyte FAK-Y861 phosphorylation in the regulation of tumour vessel regression and also in the control of pericyte derived signals that influence apoptosis in cancer cells. Overall this study identifies the role of pericyte FAK-Y861 in the regulation of tumour vessel regression and tumour growth control and that non-phosphorylatable FAK-Y861F in pericytes reduces tumour growth and blood vessel density.


Sign in / Sign up

Export Citation Format

Share Document